Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2b Trial to Evaluate the Efficacy and Safety of YH14618 in Patients With Lumbar Degenerative Disc Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs SB 01-Spine Biopharma (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Yuhan
- 08 Nov 2016 Status changed from recruiting to completed.
- 18 Feb 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 04 Jan 2016 Planned End Date changed from 1 Dec 2016 to 1 Jul 2016, according to ClinicalTrials.gov record.